Drug – bio-affecting and body treating compositions – Lymphokine – Interleukin
Patent
1993-11-08
1996-05-14
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Lymphokine
Interleukin
530351, 435 6952, 930141, 930145, A61K 3820, C07K 1454
Patent
active
055165125
ABSTRACT:
Biologically active deletion and substitution mutants of hIL-3 are provided. Preferred mutants are those having one or more deletions at the N-terminus (amino acids 1-14) and/or the C-terminus (amino acids 116-133, 120-130 and/or 130-133). Preferred substitution mutants include Cys.sup.16 .fwdarw.Ala.sup.16 and/or Cys.sup.84 .fwdarw.Ala.sup.84, Glu.sup.50 .fwdarw.Lys.sup.50 and Lys.sup.79 .fwdarw.Glu.sup.79. These mutants can be used to formulate pharmaceutical compositions. Also disclosed are antibodies directed against specific epitopes localized between amino acids 29 and 54.
REFERENCES:
patent: 4959455 (1990-09-01), Clark et al.
Kaushansky et al, J. Clin Invest 90/992, pp. 1879-88.
Dunbar et al, Science 245, 1989, pp. 1493-96.
Yang et al., Cell (1986) 47:3-10.
Dorssers et al., Gene (1987) 55:115-124.
Moonen et al., Proc. Natl. Acad. Sci. (1987) 84:4428-4431.
Kaushansky et al., Proc. Natl. Acad. Sci. (89) 86:1213-1217.
Gough et al., Eur. J. Biochem. (1987) 169:353-358.
Kuga et al., Biochem, Bopphys. Res. Commun. (1989) 159:103-111.
Makino et al., Proc. Natl. Acad. Sci. (1987) 84:7841-7845.
Mosely et al., Proc. Natl. Acad. Sci. (1984) 84:4572-4576.
Wang et al., Science (1984) 224:1431-1433.
Cohen et al., Science (1986) 234:349-352.
Zurawski et al., EMBO J. (1988) 7:1061-1069.
Robb et al., Proc. Natl. Acad. Sci. (1988) 85:5654-5658.
Collins et al., Proc. Natl. Acad. Sci. (1988) 85:7709-7713.
Clark-Lewis et al., Science (1986) 231:134-139.
Clark-Lewis et al., Proc. Natl. Acad. Sci. (1988) 85:7897-7901.
Dorssers Lambertus C. J.
Van Leen Robert W.
Draper Garnette D.
Fitzgerald David L.
Gist-brocades, N.V.
LandOfFree
N- and C-terminal truncation and deletion mutants of human inter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N- and C-terminal truncation and deletion mutants of human inter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N- and C-terminal truncation and deletion mutants of human inter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1894135